News from grifols A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 12, 2019, 09:24 ET Grifols launches XEMBIFY® (immune globulin subcutaneous human-klhw) 20%, a new Primary Immunodeficiency treatment

Grifols (MCE:GRF, MCE:GRF.P NASDAQ:GRFS), a leading global producer of plasma-derived medicines, today announced the launch of its latest...


Dec 06, 2019, 15:42 ET Grifols presents its latest Alzheimer's clinical trial data

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines, today concluded more than a year of encouraging...


Dec 05, 2019, 10:26 ET Grifols Streamlines Hospital Pharmacy Operations With New KIRO Fill® Technology and PharmacyKeeper Enhancements

Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), a leading global producer of plasma-derived medicines and provider of technologies and services for...


Dec 02, 2019, 09:17 ET Grifols to present latest Alzheimer's clinical trial results

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines, will present the final and complete clinical,...


Nov 07, 2019, 10:00 ET Grifols introduces AlphaID™, a free cheek swab to screen for Alpha-1, the most common genetic form of COPD

Grifols (MCE: GRF, MCE: GRF.P NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative...


Nov 07, 2019, 07:20 ET A Grifols se expande na América Latina com o início da produção na nova fábrica no Brasil

A Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), uma produtora líder global de medicamentos derivados do plasma e soluções para transfusão, anunciou ...


Jul 16, 2019, 02:39 ET Grifols presents additional encouraging Alzheimer's trial results at AAIC

The Grifols Clinical Research team, led by Dr. Antonio Páez, today presented additional results of its AMBAR (Alzheimer Management by Albumin...


Jul 04, 2019, 11:51 ET Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies

Grifols (MCE:GRF) (MCE:GRF.P) (NASDAQ: GRFS), a leading global producer of plasma-derived medicines, announced today that Xembify®, its new 20%...


Jul 03, 2019, 05:00 ET Grifols Selected to Build Its First Intravenous Solutions Manufacturing Line in Africa

Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), one of the world's three top providers of plasma-derived medicines to treat life-threatening...


Jun 19, 2019, 09:00 ET Grifols to launch plasma-protein-based bleeding-control solutions

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases,...


Apr 30, 2019, 06:00 ET Grifols Announces PharmacyKeeper Bidirectional Integration with Epic

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines and provider of technologies and services for...


Apr 29, 2019, 12:00 ET Grifols Announces the Opening of its new Plasma Donor Center in Hinesville, Georgia

Grifols is pleased to announce the opening of a new Biotest plasma donor center located at 108 West Hendry Street, Hinesville, Georgia. The 11,000...


Apr 18, 2019, 09:00 ET Grifols US donor centers exceed 250,000 pounds of food collected

Grifols, one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases, today announced that its U.S. network ...


Apr 15, 2019, 06:15 ET Grifols donations of blood clotting factor helping people with hemophilia globally

Grifols, one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases, today announced that its long-term...


Mar 23, 2019, 09:00 ET Grifols Announces the Opening of its new Plasma Donor Center in Russellville, AR

Grifols is pleased to announce the opening of a new Biotest plasma donor center located at 1105 W Main Street, Russellville, Arkansas. The 15,000...


Feb 21, 2019, 11:22 ET Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year

Grifols has earned the honor of 2019 Category Leader in IV Workflow Management in the 2019 Best in KLAS: Software & Services report for its...


Feb 07, 2019, 12:31 ET Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System

Grifols, a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, announced today...


Jan 08, 2019, 07:37 ET Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions

Grifols, a leading producer of plasma- derived medicines and recognized leader in transfusion medicine, has received U.S. Food and Drug...


Nov 01, 2018, 08:00 ET Grifols affirms commitment to patients during Alpha-1 Awareness Month

Alpha-1 awareness matters. Alpha-1 (alpha-1- antitrypsin deficiency) is a genetic condition that may result in serious, chronic lung disease in...


Oct 27, 2018, 03:30 ET Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's disease using its AMBAR treatment protocol

Presenting the study results, Antonio Páez, M.D., Grifols Medical Director and Head of the AMBAR Clinical Program confirmed that the analysis of...


Oct 12, 2018, 09:50 ET FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative...


Oct 08, 2018, 14:57 ET Grifols Delivers Promise of Advancing Plasma-derived Medicines through Innovative Vision and Donor Support

The importance of plasma is recognized during International Plasma Awareness Week, October 8-12. Grifols continues its commitment to plasma-derived...


Aug 16, 2018, 08:00 ET Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a global healthcare company with a history of more than 75 years of improving people's health and...


Aug 14, 2018, 08:00 ET Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative...


Jun 19, 2018, 08:25 ET Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative...